Inactive

The Vendor shall provide all labor, materials and transportation necessary to provide one (1) new, fully-automated immunoassay testing platform on a cost-per-reportable test basis with the purchase of... The Vendor shall provide all labor, materials and transportation necessary to provide one (1) new, fully-automated immunoassay testing platform on a cost-per-reportable test basis with the purchase of reagents. The system must be a fully automated, random access immunoassay system using direct or indirect chemiluminescence or fluorescence. Assay method must be able to perform FDA-approved tests capable of producing clinical results in accordance with the College of American Pathologist (CAP) and CLIP/CLIA/CLSI guidelines. Items included are the analyzer, printer, training, supplies, reagents, controls, unscheduled maintenance, and preventive maintenance for the equipment. The system will be able to test for the following analytes as listed in the Salient Characteristics: CMV IgG / IgM, HSV 1/2 IgG,Mumps IgG, Rubeola IgG, Varicella-zoster virus IgG, Lyme IgG / IgM. The Offeror is responsible for customer service and support 24 hours/7 days a week to ensure continued ability to conduct assays. This solicitation is amended to reflect new quantities on each CLIN, changing the quantity from 106,800 to 20,000.